Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-22

FDA Approved: BIJUVA — Supplemental Application (Mayne Pharma)

View source ↗

Summary

The FDA approved a supplemental application for BIJUVA (estradiol and progesterone) submitted by Mayne Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIJUVA (Estradiol and Progesterone)

Snippet

SUPPL AP for BIJUVA (ESTRADIOL AND PROGESTERONE)